Amneal Pharmaceuticals said today that it is voluntarily recalling 13 lots of its oral lorazepam product due to a defect in the dosing dropper.
In some cases, the dropper is printed with the dose markings in reverse order or has no dose markings at all, according to the Bridgewater, N.J.-based company. So far, no adverse events related to the dropper defect have been reported.
Get the full story at our sister site, Drug Delivery Business News.
The post Amneal Pharmaceuticals issues voluntary recall of lorazepam droppers appeared first on MassDevice.